stony-brook
(5)
Rushabh Shah
Rushabh Shah is the co-founder and co-CEO of AiPrise, a Y Combinator-backed (S22) global compliance platform that lets companies verify customers and businesses in more than 150 countries through a single interface. A former Meta engineer who worked on developer-focused products and payments, he started AiPrise in 2022 with Chaitanya Sarda after a weekend scramble to make a YC deadline. The company has raised roughly $14.6M, including a $12.5M Series A led by Headline in October 2025, and serves 150+ customers including Bridge (a Stripe company) and dLocal.
Yu-Sung Chang
Yu-Sung Chang is the co-founder, CEO and CTO of Vivity AI, an industrial AI company building software for heavy industries like petrochemicals, shipbuilding and manufacturing. A computer scientist with a Ph.D. from Stony Brook University, he spent years at Wolfram Research working on Mathematica's graphics and geometry systems before moving into e-commerce technology leadership as CTO of Korea's SSG.COM and co-founding the healthcare AI startup Huma.AI. In 2022 he founded Vivity AI, which raised roughly $8.4M in a round backed by Hanwha Systems, to close the gap between the physical and digital worlds on the factory floor.
J. Robert Coleman
J. Robert Coleman, PhD, MBA, is Chairman and CEO of HERVolution Therapeutics, a Copenhagen-based biotech developing immunotherapies that target human endogenous retroviruses (HERVs) - the ancient viral DNA lodged in the dark genome that reawakens in cancer, aging, and neurodegeneration. A trained virologist, he co-founded Codagenix, where he built a synthetic-biology vaccine platform into a clinical-stage pipeline and raised nearly half a billion dollars before pivoting to HERVs in late 2023.
Yunfei Cao
Yunfei 'Richard' Cao is the co-founder and CEO of Angio8 (通甪科技), a Shenzhen-based startup building a next-generation surgical robot for minimally invasive vascular interventional surgery. A Stony Brook biomedical engineer who cut his teeth inside the Boston medical-device machine at Vention Medical, SunMed and China Med Device, Cao now runs a cross-Pacific company - engineering brains in Boston, manufacturing and clinical work in Shenzhen - aimed at letting doctors steer catheters and guidewires by robot instead of by hand.
Hal Paz
Hal Paz (Harold L. Paz, M.D., M.S.) is an Operating Partner at Khosla Ventures, where he focuses on digital healthcare innovation and AI-driven health solutions. A physician-scientist and seasoned health system CEO, he has led multi-billion-dollar enterprises at CVS Health/Aetna, Ohio State University Wexner Medical Center, Penn State Health, and Stony Brook University Medicine. He has served as a medical school dean twice over - first at Robert Wood Johnson, then at Penn State - and has authored over 100 papers on sepsis, ARDS, and medical devices. Now at one of Silicon Valley's most ambitious venture firms, he bridges the worlds of clinical medicine and frontier technology, helping founders navigate the notoriously complex terrain of American healthcare.